Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Retatrutide (LY3437943) 99% Purity Peptide
Retatrutide (LY3437943) 99% Purity Peptide buy - large image1
Retatrutide (LY3437943) 99% Purity Peptide buy - image1
Retatrutide (LY3437943) 99% Purity Peptide buy - image2
Retatrutide (LY3437943) 99% Purity Peptide buy - image3
Retatrutide (LY3437943) 99% Purity Peptide buy - image4
Retatrutide (LY3437943) 99% Purity Peptide buy - image5
Retatrutide (LY3437943) 99% Purity Peptide buy - image6

Retatrutide (LY3437943) 99% Purity Peptide

7234 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharma Grade / Research Grade / HPLC Grade

Content:

99%

Port:

Shenzhen

Brand:

Boruimei

Packaging:

5mg*10vials, 10mg*10vials, 15mg*10vials, 20mg*10vials, 30mg*10vials, 40mg*10vials, 60mg*10vials

Price valid (until):

2026-06-17

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Polypeptide Products

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Contact Us   


    Name:Jeck Moss

    Telegram:+852 5603 8853

    Whatsapp:+852 5603 8853

    Email Address:sales@boruimei.com


      Product Detail  


    Shop Retatrutide (LY3437943) 99% Purity Peptide-Detailed Image 1

    Items Specifications
    Product Name:    Retatrutide
       CAS: 2381089-83-2
       Purity 99%
       Shelf life: 24 months
       Specification: 10mg/vial 10vials /box
       Appearance:

    Lyophilized powder

    Product Features

    • High Purity: The purity is ≥98% (HPLC), single impurity ≤0.5%, which meets the enterprise quality standard and can provide COA report to ensure product quality and reliability.
    • Stable Performance: Lyophilized powder form has ultra-high stability, which is convenient for storage and transportation, and can effectively maintain the activity of the product.
    • Clear Mechanism: As a triple receptor agonist, it can simultaneously activate GLP-1, GIP and GCGR receptors, and has important research value in metabolic regulation-related research fields.
      Shop Retatrutide (LY3437943) 99% Purity Peptide-Detailed Image 2

      Clinical Efficacy

      1. Obese people (68 weeks trial)

      • 9mg weekly group: Average weight loss 24.2%
      • 12mg weekly group: Average weight loss 28.7%
      • Placebo group: Only 4.6% weight loss

      2. Type 2 Diabetes patients

      Reduce HbA1c by 2.5%–3.0%; average weight loss 18%–22%.

      Extra benefits

      Greatly reduce liver fat content; relieve joint pain; improve blood pressure, blood lipids and cardiovascular indicators.

    • Shop Retatrutide (LY3437943) 99% Purity Peptide-Detailed Image 3
    • Specifications

      • Purity: ≥99% (HPLC)
      • Peptide Content: ≥98%
      • Water Content: ≤5%
      • Residual Solvents: Meet ICH Q3C
      • Endotoxin: ≤10 EU/mg

      Package & Delivery

      • Packing: 5mg*10vials, 10mg*10vials, 15mg*10vials, 20mg*10vials, 30mg*10vials, 40mg*10vials, 50mg*10vials, 60mg*10vials, 100mg*10vials, 120mg*10vials
      • Shop Retatrutide (LY3437943) 99% Purity Peptide-Detailed Image 4
        • Lead time: In stock, 2–3 working days after payment.
        • Documents: COA, HPLC, MS, TDS, SDS available upon request.

        Quality Assurance

        • Strict QC: HPLC, MS, moisture, residual solvents, endotoxin.
        • GMP-like production environment, traceable batch records.
        • Custom synthesis and bulk supply supported.


      Why Choose Us  


    • 1.High quality products with competitive pricing.
    • 2.Free samples available for your evaluation and testing.
    • 3.Fast, reliable delivery via reputable shipping lines.
    • 4.Trial orders are welcome for quality verification after sample approval.
    • 5.Proactive updates and full transparency at every stage of your order.
    • 6.Custom packaging solutions tailored to meet your specific requirements.


    Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 3



      Our factory  


    Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 4 Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 5 Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 6


      How to order  


    Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 7


      Delivery time  


    • USA: 7-12days (tax included)

    • Europe: 7–12 days (tax included)

    • Australia: 7–12 days (tax included)

    • Canada: 7–12 days (tax included)

    • Asia and Southeast Asia: 5–10 days (tax included)

    • Free redelivery is available if the parcel fails to arrive on time.

    FAQ

    1.Can we get your free samples?

    Yes, can. Our free sample can be provided for customers test. But the freight for express is obuyer's account.

    2.Can we do printing or label on the bottles?

    Yes, can. We can offer various printing ways,such, screen printing, hot stamping, label printing.

    3.What is the normal lead time?

    For stock products, within 24-48 hours after we receive your payment. For smaller customize color bottles, we will ship out within 3-5 days.

    4.What is your shipping terms?

    Faster ways: FEDEX, DHL, UPS, TNT, etc by sea or by air economy

    5.How does your factory do regarding quality control?

    We do test for 3 times before packing.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Polypeptide Products

    Location:

    No. 917, 9th Floor, Unit 1, Building 19, Shengshi Huayuan Business Center, Shunhua Road Sub-district, High-tech Zone, Jinan City, Shandong Province

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

  • Inquiry History
    7234 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    United States

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    20 MG Feb 4, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.